| Date Filed | Type | Description |
| 02/07/2014 |
SC 13G/A
| JENNISON ASSOCIATES LLC reports a 0% stake in Map Pharmaceuticals, Inc. |
| 02/07/2014 |
SC 13G/A
| PRUDENTIAL FINANCIAL INC has filed a Schedule 13D for MAP Pharmaceuticals, Inc. |
| 03/13/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/13/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/13/2013 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 03/11/2013 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 03/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/11/2013 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 03/11/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/11/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/11/2013 |
POS AM
| Form POS AM - Post-Effective amendments for registration statement |
| 03/05/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2013 |
4
| CHAI CHRISTOPHER Y (SVP, CFO) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| KELLEY BERNARD J (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| NELSON TIMOTHY S (President and CEO) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| ARMER THOMAS A (Chief Scientific Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| Friedman Charlene A (SVP, Gen Counsel & Sec) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| GIANAKAKOS ANASTASIOS (SVP, Chief Business Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| KELLERMAN DONALD J (SVP,Clinical Dev & Med Affairs) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Unknown transaction of 3,795 shares
@ $25, valued at
$94.9k
Disposed/sold 61,450 options to buy
@ $9.2, valued at
$565.3k
Disposed/sold 29,500 options to buy
@ $10.37, valued at
$305.9k
Disposed/sold 55,000 options to buy
@ $16.19, valued at
$890.5k
Disposed/sold 27,500 options to buy
@ $16.15, valued at
$444.1k
Disposed/sold 32,500 options to buy
@ $14.09, valued at
$457.9k
Disposed/sold 4,500 restricted stock units
@ $0
Disposed/sold 8,250 restricted stock units
@ $0 |
|
| 03/04/2013 |
4
| Borland Scott (SVP, Neurology Franchise) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| Wolff Henry Ward (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 30,000 options to buy
@ $12.74, valued at
$382.2k
Disposed/sold 7,500 options to buy
@ $3.18, valued at
$23.9k
Disposed/sold 7,500 options to buy
@ $14.77, valued at
$110.8k
Disposed/sold 7,500 options to buy
@ $16.47, valued at
$123.5k
Disposed/sold 10,000 options to buy
@ $11.69, valued at
$116.9k
|
|
| 03/04/2013 |
4
| WARD SCOTT R (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| OSHEA WILLIAM J (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 20,000 options to buy
@ $13.79, valued at
$275.8k
|
|
| 03/04/2013 |
4
| HENWOOD GERALDINE (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| GIANAKAKOS ANASTASIOS (SVP, Chief Business Officer) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
4
| HENWOOD GERALDINE (Director) has filed a Form 4 on MAP Pharmaceuticals, Inc. |
| 03/04/2013 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in MAP Pharmaceuticals, Inc. |
| 03/01/2013 |
8-K
| Quarterly results |
| 03/01/2013 |
SC 14D9/A
| Form SC 14D9/A - Solicitation, recommendation statements: [Amend] |
| 03/01/2013 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 03/01/2013 |
SC 13D/A
| MAP Pharmaceuticals, Inc. reports a 85.5% stake in MAP Pharmaceuticals, Inc. |
| 02/11/2013 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
| 02/11/2013 |
SC 13G/A
| MAP Pharmaceuticals, Inc. reports a 6.9% stake in Map Pharmaceuticals, Inc. |
|